[Asia Economy Reporter Hwang Yoon-joo] Celltrion announced on the 11th that it has signed a supply contract for the COVID-19 antigen rapid diagnostic kit Diatrust worth 459.4 billion KRW.



This amount corresponds to 24.8% of recent sales, and the contract counterpart is its subsidiary, Celltrion's U.S. corporation.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing